
Noah Hamman
12
APPEARANCES
3
PODCASTS
024
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Oct 7, 2026
AlphaNooner - What Mattered This Week in the Markets?
26:33
26:51
26:58
27:13

Noah HammanGUEST
Dan, uh, you know, I, I gotta go back and look at the numbers, but I think the funny thing is, like, last I, last I saw, and I don't remember what the timeframe was, uh, it's probably changed since then, right? 'Cause once we s- once we had the redemption, um, we went to negative flows for the year.

Noah HammanGUEST
Um, so between that and then obviously some of the sales and the adjustments, you know, we're down in terms of that position.

Noah HammanGUEST
Um, but again, and I posted this yesterday, um, when you think about what's been leading the cannabis space, right, fund aside, um, obviously the two big ones of, you know, Curaleaf and, uh, Trulieve, uh, have been dominating, you know, the performance numbers there.

Noah HammanGUEST
Um, Green Thumb obviously is, is lagged, which again, um, any selling of that, uh, of, of a small stock like that, right, is gonna put downward pressure on it.
9 MINS LATER
AlphaNooner - What Investors Should Take Away From This Week
12:29
12:42

Noah HammanGUEST
Um, but I couldn't tell you who or why or, you know, in part what, what their advantage is, right? Some of them say because they're the writers of the options on the part of the other people buying long options.

Noah HammanGUEST
But I would think over time, why would you keep buying options if you know you're gonna lose money, and you genuinely think this is pegged at a number that it won't go over, but the same people keep buying those same options over and over again? It, it almost doesn't make sense to me.
31 MINS LATER
43:43
Um, I know you were also at a conference, I wanna say a week, two weeks ago? Uh, wanted to see if there were-
AlphaNooner - Live from NYC: The Week in Markets
19:50
20:03

Noah HammanGUEST
Uh, people gotta do what they want, right? This is a, a volatile, volatile space, right? I, I think I was responding to someone's question about, um, leverage strategies in this space, right? I can't mention products specifically.

Noah HammanGUEST
Um, and they were looking at the longer term performance and pretty much every leverage product out there, um, that at least is, you know, trying to get a multiple of something is all based on a one day, you know, investment, um, uh, objective.
9 MINS LATER
AlphaNooner - Markets in Focus with Noah Hamman
0:00
0:11
0:30
0:46
0:54
1:04
14:20

Noah HammanGUEST
ongoing it was a year or so ago when Trump, uh, and the administration, I guess, put through this whole, uh, most favored nation stuff relative to pharmaceutical drugs and Trump RX and whatever else.

Noah HammanGUEST
Um, and roughly the net result is lower drug prices here for people in the US, um, but also somewhat, um, I think, uh, increased prices in different areas internationally, right? So the only way for pharmaceutical companies wasn't just to charge less in the US, it was just to raise the prices, [chuckles] you know, everybody else.

Noah HammanGUEST
Um, so, you know, even when you've got some overlap like these companies do, um, I think if you can save money, right, on research and development, and you're, you're kind of in the same category, and you can find some efficiencies and bring a lot of s- more smart people together, hopefully.

Noah HammanGUEST
Um, and then you've got this increased, you know, global footprint that allows you to sort of, allows you to, you know, distribute your products more easily globally.

Noah HammanGUEST
I think AstraZeneca, the numbers I looked up, fifty-seven percent of their, uh, revenue was outside the US and, um, a far lower number for, for Bristol Myers Squibb.

Noah HammanGUEST
So they kind of balance each other out in, in terms of their, uh, global footprint.
13 MINS LATER

Noah HammanGUEST
Which they certainly do with SNAP benefits and things like that, right? All the other existing government programs to get you affordable food and, and care, um, is obviously paid for by the taxpayers.
Glass House Rings the Bell at the NYSE | TTB on Location
21:50
21:56

Shadd DalesHOST
it feels like there's a little positive sentiment from a pure capital markets perspective on what's been developing the last couple of weeks

Noah HammanGUEST
there is you get to see it here firsthand you get to feel it firsthand uh look at something like trulieve and glasshouse both of them their volumes have picked up as they've got a better venue to trade and for people to get access to their stock there's some work to do right to get institutions you know buying in size but that's some of the industry changes that you're talking about a regulatory changes that as those come and it starts to become becomes something that can be investable by big institutions, the price action's gonna start to change dramatically, I believe.
MSOS Rings NYSE Bell, Cannabis Enters New Phase | TTB on Location
28:48
29:08
29:16

Shadd DalesHOST
I had a great conversation with Dan this morning on the way down here, but what does this mean for you, both personally and professionally? It's been almost six years to the day that this ETF began trading, and finally it's being fully embraced, which is a, I think, long overdue,

Noah HammanGUEST
It's access to the capital markets, right? Companies around the want to be listed in the U.S., particularly the New York Stock Exchange.

Noah HammanGUEST
And for this industry in particular, it needs access to the kind of capital that flows through this organization.
EV Sales & Robotaxi Future Key in TSLA Growth, Outlining Earnings Expectations
2:44
3:14
3:21
3:29
S
2:33Sam VadasHOST
What has Musk & Co got to say about autonomy and AI as far as reassuring investors about the future bets for this company?

Noah HammanGUEST
i think it's just that right he is going to say this is the future right and i think you'll have an opportunity to speak to the growth of robo taxi i think they're on their seventh city now just announcing i think tampa and orlando um hopefully we're going to see phoenix and vegas i know that we're in their short-term plans um you know the big talk has been whether or not they can compete with waymo and the differences they take in their approach of technology around unsupervised self-driving, and it seems to be working.

Noah HammanGUEST
And so I think that's what he's going to talk about is that what they're seeing is their approach is working.

Noah HammanGUEST
And the differences in the business models are significant where someone like me or you can buy our own car and then put that car out to work if we want to.

Noah HammanGUEST
I think it's dramatically different in terms of what the other competitors are doing out there.
S
4:47Sam VadasHOST
I'm just wondering as far as what we hear tonight, is this a Tesla story or a market story?
Historic Week in Cannabis | Live from Glass House (NYSE:GLAS) | TTB Presented by Flowhub
13:01
13:09
13:16
13:31
13:36

Shadd DalesHOST
So what's your message to our viewers out there that are wondering why is there no inflows and what does this mean as far as the future?

Noah HammanGUEST
So I probably have a message in general about how ETFs work and maybe just a little bit of history, which is in general how ETFs work.

Noah HammanGUEST
Yes, you know, we didn't see any inflows from what, about a month, a month and a half ago to two months ago when the numbers were ramping up and the volume was really crazy.

Noah HammanGUEST
So as a market maker, right, they're the ones that ultimately decide whether or not they're going to create or redeem.

Noah HammanGUEST
And they're making that decision to remember these guys are trading on fractions of a penny.
14 MINS LATER
Noah Hamman Favors Hardware Over Software, Sees Yellow Flag on Consumer Spending
1:11
1:20
1:28
S
0:49speaker_0HOST
so in the long run if it's going to be strong you think these are buying opportunities then what kind of tech specifically there's so much within tech would you recommend buying on the dips i mean for example the nasdaq's down three weeks in a row right now it's holding on to some gains but i don't know where it's going to end the week right

Noah HammanGUEST
This is a great opportunity to sort of look at your weighting in different categories.

Noah HammanGUEST
But the challenge, I think, with all of that is the spending relative to the AI story and the results that we get from these AI software services.

Noah HammanGUEST
Software itself has been down 20%, and that's probably not an area that I would lean into as an investor.
S
4:15speaker_0HOST
What do you think about the consumer? The consumer is going to drive everything one way or another, right?
"Meeting Customers Where They Are:" PYPL & SOFI Show Fintech Adaptability
2:53
S
2:51speaker_0HOST
What do you think of that?

Noah HammanGUEST
it'll be interesting right it'll be one more example of seeing how the public markets value these ai companies i'll be curious to same to see if it's at the same levels but given their growth i think what i saw with the paypal news is that's access for paypal to roughly 200 million users on chat gpt obviously one of the leading ai providers so i think going to the public markets will be interesting to see where it's valued but probably also good for chat gpt as well so they can use the equity markets to continue to fuel their growth But again, great opportunity for PayPal to integrate more with them.
S
5:12speaker_0HOST
Why is that? What else do you look at here, Noah?
Hamman: No AI Bubble, Still in Early Innings
2:29
2:59
3:10
3:17
S
2:17speaker_0HOST
Are there any names that you wanted to focus on in particular? I mean, for example, tomorrow we have Texas Instruments, Lockheed Martin, Verizon, GE, Coca-Cola, 3M, Netflix, just to name a few.

Noah HammanGUEST
sure i think you know a lot of those those companies are sort of hit from very different angles right something like a lockheed versus a ge um i think in general it seems like these companies have been revising their expectations higher right obviously it depends on the specific company and in general where we've seen with some of these more industrial companies how they've been impacted by tariffs so each individual company is going to matter But I think as you're looking at the AI space, what I would think about it is in terms of storage, chips, and then software.

Noah HammanGUEST
Some of the best performing stocks are this year, Western Digital and Seagate Technology, Micron, which you mentioned, or the software solution providers around it like Palantir.

Noah HammanGUEST
And of course, AMD and Intel, of course, outstanding performance this year, broadly exceeding the broader market.

Noah HammanGUEST
So I think we'll continue to see this earnings growth and the upward revision of expectations.
S
5:38speaker_0HOST
you talked about cannabis and mid and small caps tell me about each of those
Cheaper Tesla Model Y & Model 3 "Sweet Spot" for Price, TSLA Sells Off
1:11
1:33
1:38
4:37
4:48
1:02
grok ai tesla theater tesla arcade and long range and affordability noah your thoughts

Noah HammanGUEST
i like it it's a great idea some of the features you mentioned there will probably be up charges right there'll be annual fees associated with some of those things so some additional income from a lower priced car but it's going to allow them to compete where they've had the most competition um right the equinox gmzv equinox has been a hot seller at 35 000 competing internationally with BYD.

Noah HammanGUEST
So this is good news coming at a good time when people are losing some of their tax credits associated with buying Teslas.

Noah HammanGUEST
And if Tesla has what they believe is a superior car, this price point will make them that much stronger.
4:00
Noah, what are your thoughts here in the competitive landscape? I mean, Tesla really was the original EV maker, went back and forth on which, between BYD, which one sold more, but still had a great number when it came to deliveries in the last quarter was a record and energy was a record and humanoid robots are coming and this has full self-drive capability with supervision and grok ai and more is this a winning company going forward at 439 folks may be scratching their head and saying maybe yes or maybe no what do you think

Noah HammanGUEST
They're just beginning to scale that and they seem to have a model for autonomous driving, at least relative to things like taxi service where they can significantly scale.

Noah HammanGUEST
Waymo's got a significant advantage over them now, But what they look like a year or two will be, I think, dramatically different.

